Cancer drug combo study halted early
NCT ID NCT05580770
First seen May 02, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tested a combination of two experimental drugs, mirdametinib and BGB-3245, in adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and see if the combo could shrink tumors. The study was terminated early after enrolling 23 people, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Calvary Mater Newcastle
Waratah, 2298, Australia
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Texas Oncology-Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
Yale-New Haven Hospital-Yale Cancer Center
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.